Tokyo, March 31 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060966) titled 'The Nationwide Registration Initiative for Lung Malignancy in Japan' on March 31.
Study Type:
Observational
Primary Sponsor:
Institute - Shizuoka Cancer Center
Condition:
Condition - Small Cell Lung Cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate real-world reatment patterns and clinical outcomes of patients with small cell lung cancer in Japan
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1, Pathologically diagnosed as small cell lung cancer after 27th March 2025
2, 18 years or older at time of diagnosed as small cell lung cancer
3, Provided written informed consent
Key exclusion criteria - None
Target Size - 775
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 09 Month 14 Day
Date of IRB - 2026 Year 01 Month 08 Day
Anticipated trial start date - 2026 Year 03 Month 01 Day
Last follow-up date - 2031 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069716
Disclaimer: Curated by HT Syndication.
